參考資料 :

1. Mercilon Prescribing Information. Organon Hong Kong. 2021.
2. Lammers P and Op Ten Berg M. Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiol. Acta Obstet Gynecol Scand. 1991;70:497-500.
3. WHO Family planning- A global handbook for providers. 2022 Edition. Available from: https://www.who.int/publications/i/item/9780999203705. [Accessed 3 Nov 2023].
4. Marvelon Prescribing Information. Organon Hong Kong. 2021.
5. Bilotta P & Favilli S. Clinical Evaluation of a Monophasic Ethinylestradiol/ Desogestrel-containing Oral Contraceptive. Arzneim. Forsch. 1988;38(II)7:932-4.
6. Teal S & Edelman A. Contraception Selection, Effectiveness, and Adverse Effects. JAMA. 2021 ;326(24):2507-8.
7. Yang M & Li Z. The development history of oral contraceptives. Zhonghua Yi Shi Za Zhi. 2021;51(2):92-6.
8. American College of Obstetricians and Gynecologists. (2024). FAQs: Emergency contraception (FAQ114).
9. Drug Office. Drugs Database. MERCILON. Available from: https://www.drugoffice.gov.hk/eps/drug/productDetail/en/pharmaceutical_trade/156092. [Accessed 19 Nov 2025].
10. IQVIA Q32025 G03 Market
11. European Medical Agency. Available from: https://ec.europa.eu/health/documents/community-register/2015/20150716132227/anx_132227_en.pdf. [Accessed 19 Nov 2025].
12. Taiwan Food and Drug Administration. Available from: https://www.fda.gov.tw/tc/newsContent.aspx?cid=5049&id=25146. [Accessed 19 Nov 2025].
13. United Nations. Department of Economic and Social Affairs. Contraceptive Use by Method 2019. Available from: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/files/documents/2020/Jan/un_2019_contraceptiveusebymethod_databooklet.pdf#:~:text=In%20Europe%20and%20Northern%20America%2C,and%2014.9%20per%20cent%2C%20respectively). [Accessed 19 Nov 2025].
14. Drug Office. Oral Contraceptives. Available from: https://www.drugoffice.gov.hk/eps/do/tc/consumer/news_informations/knowledge_on_medicines/oral_contraceptives.html. [Accessed 19 Nov 2025].
15. Formosan Medical Association. Available from: https://www.fma.org.tw/2015/E-2-1.html. [Accessed 19 Nov 2025].
16. TFDA. Available from: https://article-consumer.fda.gov.tw/subject.aspx?subjectid=2&id=3598&parentid=68. [Accessed 19 Nov 2025].
17. Arora MK, et al. Role of hormones in acne vulgaris. Clin Biochem. 2011 Sep;44(13):1035-1040.
18. Oesterheld JR, et al. Oral contraceptives. Psychosomatics. 2008 Mar-Apr;49(2):168-75.
19. Cleveland Clinic. Progesterone Capsules. Available from: https://my.clevelandclinic.org/health/drugs/19484-progesterone-capsules. [Accessed 19 Nov 2025].
20. Cleveland clinic. Irregular Periods. Available from: https://my.clevelandclinic.org/health/diseases/14633-abnormal-menstruation-periods. [Accessed 19 Nov 2025].
21. Taiwan Association of Obsterics and Gynecology. 口服避孕. Available at: https://www.beok.org.tw/oral-contraceptives/. [Accessed 16 Dec 2025].
22. Rosenberg MJ, et al. Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations. Contraception. 1999 Dec;60(6):321-9.
23. Data on file